MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jha2.442

Медицинская библиотека · EJHaem · 2022

Non-factor therapies for bleeding disorders: A primer for the general haematologist.

Swan Dawn, Mahlangu Johnny, Thachil Jecko

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Management of patients with severe bleeding disorders, particularly haemophilia A and B, and to a lesser extent, von Willebrand disease, has come on leaps and bounds over the past decade. Until recently, patients relied upon the administration of factor concentrates to prevent or treat bleeding episodes. Factor administration requires intravenous access and, in up to one-third of patients, leads to the development of neutralising antibodies, or inhibitors, which are associated with more frequent bleeding episodes and higher morbidity. Novel non-factor therapies may offer a solution to these unmet needs. In this review, we discuss the factor mimetics, particularly emicizumab, and the rebalancing agents, which inhibit antithrombin, tissue factor pathway inhibitor and activated protein C, and novel treatments to enhance von Willebrand factor levels. We review the available trial data, unanswered questions and challenges associated with these new treatment modalities. Finally, we provide practical management algorithms to aid the general haematologist when faced with a patient receiving emicizumab who requires surgery or may develop bleeding.

Для цитирования: Swan Dawn, Mahlangu Johnny, Thachil Jecko. Non-factor therapies for bleeding disorders: A primer for the general haematologist.. EJHaem. 2022. DOI: 10.1002/jha2.442.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.